3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance-Reference-Cited by-同舟云学术

3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance

Published:2024-06-11 Issue:7 Volume:10 Page:2419-2442
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Pou Sovitj¹,Winter Rolf W.¹,Dodean Rozalia A.¹^ORCID,Liebman Katherine¹,Li Yuexin¹,Mather Michael W.²,Nepal Binod²,Nilsen Aaron¹³^ORCID,Handford Mason J.³,Riscoe Teresa M.⁴,Laxson Sydney¹,Kirtley Payton J.⁵,Aleshnick Maya⁵,Zakharov Lev N.⁶,Kelly Jane X.¹^ORCID,Smilkstein Martin J.¹,Wilder Brandon K.⁵,Kortagere Sandhya²,Vaidya Akhil B.²^ORCID,Alday P. Holland¹⁷^ORCID,Doggett J. Stone¹⁷^ORCID,Riscoe Michael K.¹⁴^ORCID

Affiliation:

1. VA Portland Healthcare System, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, United States

2. Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 19129, United States

3. Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States

4. Department of Microbiology and Molecular Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States

5. Vaccine & Gene Therapy Institute (VGTI), Oregon Health and Science University (West Campus), 505 NW 185th Avenue, #1, Beaverton, Oregon 97006, United States

6. Center for Advanced Materials Characterization in Oregon (CAMCOR), 1443 E. 13th Avenue, Eugene, Oregon 97403, United States

7. School of Medicine Division of Infectious Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States

Funder

U.S. Department of Veterans Affairs

National Institute of Allergy and Infectious Diseases

U.S. Department of Defense

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.4c00140

Reference43 articles.

1. Artemisinin Resistance inPlasmodium falciparumMalaria

2. Evidence of Artemisinin-Resistant Malaria in Africa

3. New developments in anti-malarial target candidate and product profiles

4. Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria